10x Genomics Inc - Ordinary Shares - Class A

NASDAQ:TXG   10:18:07 AM EDT
177.76
-2.13 (-1.18%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)19.13B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$100.27 Million
Adjusted EPS-$0.14
See more estimates
10-Day MA$165.34
50-Day MA$147.87
200-Day MA$112.31
See more pivots

10x Genomics, Inc. Stock, NASDAQ:TXG

6230 STONERIDGE MALL ROAD, PLEASANTON, CA 94588
United States of America
Phone: (925) 401-7300
Number of Employees:

Description

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems. It offers chromium instruments, enzymes, reagents, microfluidic chips, and other consumable products, as well as software for analyzing biological systems. The company serves researchers in approximately 40 countries. Its customers include a range of academic, government, biopharmaceutical, biotechnology, and other institutions worldwide. 10X Genomics, Inc. was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. The company was incorporated in 2012 and is based in Pleasanton, California.